Taro-Deferasirox 125 mg

TARO-DEFERASIROX 125 MG is an oral tablet for suspension used for managing iron overload. This medication is designed to help reduce excess iron in the body, often associated with certain medical conditions. It is manufactured by TARO Pharmaceuticals Inc. in Canada.

TARO-DEFERASIROX 125 MG is primarily used to manage iron overload in the body. This condition can occur due to frequent blood transfusions or other medical treatments. The medication helps to reduce the amount of iron in the body, which can be beneficial for overall health. It is often prescribed for individuals who require regular blood transfusions or have conditions that lead to iron accumulation.

Common effects of TARO-DEFERASIROX 125 MG may include gastrointestinal issues such as nausea, vomiting, or diarrhea. Some users might experience skin rashes or changes in skin color. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

TARO-DEFERASIROX 125 MG should be handled with care. It is important to follow the prescribed dosage and administration instructions. The medication should be stored in a cool, dry place away from direct sunlight. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

TARO-DEFERASIROX 125 MG may interact with certain medications, including those that affect liver enzymes. It is important to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting any new medication while on TARO-DEFERASIROX.